Sort   by:  
 Page size 
Chimeric antigen receptor (CAR) therapy targeting CD19 yielded remarkable outcomes in patients with acute lymphoblastic leukemia. To identify potential CAR targets in acute myeloid leukemia (AML), we probed the AML surfaceome for over-expressed molecules with potentially tolerable systemic expressio...
ORGANISM(S): Homo sapiens (Human) 
2017-10-24 | PXD007552 | Pride
Sort   by:  
 Page size